Cargando…
High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo
BACKGROUND: The strong association between aberrant HDAC activity and the occurrence of cancer has led to the development of a variety of HDAC inhibitors (HDIs), which emerge as promising new targeted anticancer therapeutics. METHODS: Due to the pivotal role of RelA/p65 in the tumorigenesis of pancr...
Autores principales: | Lehmann, Annika, Denkert, Carsten, Budczies, Jan, Buckendahl, Ann-Christin, Darb-Esfahani, Silvia, Noske, Aurelia, Müller, Berit Maria, Bahra, Marcus, Neuhaus, Peter, Dietel, Manfred, Kristiansen, Glen, Weichert, Wilko |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779818/ https://www.ncbi.nlm.nih.gov/pubmed/19912635 http://dx.doi.org/10.1186/1471-2407-9-395 |
Ejemplares similares
-
An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas
por: Noske, Aurelia, et al.
Publicado: (2011) -
High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis
por: Weichert, W, et al.
Publicado: (2007) -
Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover
por: Denkert, Carsten, et al.
Publicado: (2008) -
Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
por: Müller, Berit Maria, et al.
Publicado: (2013) -
Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy
por: Darb-Esfahani, Silvia, et al.
Publicado: (2009)